Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$444K Sell
6,400
-69
-1% -$5.12K 0.03% 514
2022
Q1
$497K Buy
6,469
+291
+5% +$20.9K 0.03% 517
2021
Q4
$473K Sell
6,178
-923
-13% -$67.8K 0.03% 526
2021
Q3
$524K Buy
7,101
+123
+2% +$9.22K 0.04% 472
2021
Q2
$466K Sell
6,978
-486
-7% -$32.5K 0.03% 527
2021
Q1
$555K Sell
7,464
-107
-1% -$8.12K 0.04% 452
2020
Q4
$551K Buy
7,571
+892
+13% +$63K 0.04% 429
2020
Q3
$444K Buy
6,679
+273
+4% +$17.3K 0.04% 427
2020
Q2
$365K Buy
6,406
+204
+3% +$10K 0.03% 456
2020
Q1
$217K Buy
+6,202
New +$295K 0.03% 526
2018
Q1
Sell
-4,817
Closed -$209K 585
2017
Q4
$209K Buy
+4,817
New +$192K 0.04% 529
2017
Q3
Sell
-4,682
Closed -$212K 491
2017
Q2
$212K Sell
4,682
-43
-0.9% -$1.9K 0.05% 426
2017
Q1
$201K Buy
+4,725
New +$193K 0.05% 416

Other funds holding HOLX

Advisor Partners's HOLX Position: Q2 2022 in Review

Advisor Partners reduced its Hologic (HOLX) stake by 1.1% in Q2 2022, selling an estimated $5.12K and leaving 6,400 shares worth $444K. The position accounts for 0.03% of the portfolio, ranked #514.

Advisor Partners first reported a position in HOLX in Q1 2017 and has held it in 13 quarters since. The position peaked at $555K in Q1 2021. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Advisor Partners held 6,400 shares of Hologic worth $444K as of Q2 2022.
  • Advisor Partners sold 69 Hologic shares in Q2 2022, an estimated $5.12K.
  • Hologic made up 0.03% of Advisor Partners's portfolio in Q2 2022, its #514 holding.
  • Advisor Partners first reported a position in Hologic in Q1 2017 and has held it in 13 quarters since.
  • Advisor Partners's Hologic position peaked at $555K in Q1 2021.
  • 695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.